Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$451.22
-0.9%
$465.00
$408.42
$623.60
$6.63B0.46176,749 shs174,873 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$179.16
-0.3%
$175.04
$146.17
$185.62
$20.10B0.46860,361 shs559,951 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$275.19
-1.5%
$262.43
$209.38
$283.47
$23.21B0.78514,749 shs298,517 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$472.94
-0.1%
$392.42
$250.05
$501.30
$13.30B1.42356,826 shs202,838 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-1.21%-0.75%-3.40%-21.48%-21.15%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-0.29%-2.42%+6.73%+3.52%+15.73%
Labcorp Holdings Inc. stock logo
LH
Labcorp
-1.56%-0.48%+5.29%+10.69%+19.29%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-0.11%+4.32%+5.59%+59.53%+24.13%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chemed Corporation stock logo
CHE
Chemed
4.9926 of 5 stars
3.44.03.34.93.73.32.5
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.7365 of 5 stars
2.32.04.24.72.22.52.5
Labcorp Holdings Inc. stock logo
LH
Labcorp
4.6697 of 5 stars
2.35.02.54.23.02.51.3
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.3199 of 5 stars
2.03.00.04.63.64.21.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
2.75
Moderate Buy$579.7528.49% Upside
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.50
Moderate Buy$186.003.82% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.62
Moderate Buy$290.335.50% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
1.93
Reduce$406.60-14.03% Downside

Current Analyst Ratings Breakdown

Latest CHE, MEDP, LH, and DGX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$311.00
8/25/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/25/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Neutral$194.00
7/31/2025
Chemed Corporation stock logo
CHE
Chemed
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$640.00 ➝ $589.00
7/31/2025
Chemed Corporation stock logo
CHE
Chemed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$650.00 ➝ $580.00
7/29/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$300.00 ➝ $305.00
7/25/2025
Chemed Corporation stock logo
CHE
Chemed
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$500.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$282.00 ➝ $305.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$290.00 ➝ $310.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$285.00 ➝ $300.00
7/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$283.00 ➝ $306.00
(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.43B2.70$25.48 per share17.71$82.25 per share5.49
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$10.52B1.90$13.46 per share13.31$64.97 per share2.76
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.01B1.76$22.07 per share12.47$101.96 per share2.70
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B6.30$13.93 per share33.94$6.14 per share77.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$302M$19.4523.2019.372.5111.56%25.83%17.77%11/4/2025 (Estimated)
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$871M$8.3521.4617.082.399.01%15.24%6.64%10/28/2025 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$746M$9.0630.3715.691.795.66%15.45%7.02%10/23/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.4535.1634.622.9818.74%67.66%21.86%10/20/2025 (Estimated)

Latest CHE, MEDP, LH, and DGX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025Q2 2025
Chemed Corporation stock logo
CHE
Chemed
$6.02$4.27-$1.75$3.57$650.60 million$618.80 million
7/24/2025Q2 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion
7/22/2025Q2 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billion
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.00$3.10+$0.10$3.10$537.70 million$603.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.400.53%N/A12.34%16 Years
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.201.79%N/A38.32%14 Years
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.881.05%N/A31.79%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A

Latest CHE, MEDP, LH, and DGX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/13/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.801.79%10/3/202510/3/202510/20/2025
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.05%8/28/20258/28/20259/11/2025
8/1/2025
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.600.6%8/11/20258/11/20258/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
N/A
1.86
1.83
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.71
1.09
0.99
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.61
1.50
1.32
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.43
0.43

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.29%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
8.16%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,69514.57 million14.09 millionOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
56,000111.82 million102.70 millionOptionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
70,00083.10 million82.40 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.09 million22.39 millionOptionable

Recent News About These Companies

COR vs. MEDP: Which Stock Is the Better Value Option?
Brokerages Set Medpace Holdings, Inc. (NASDAQ:MEDP) Price Target at $406.60

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Chemed stock logo

Chemed NYSE:CHE

$451.22 -4.11 (-0.90%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$452.06 +0.84 (+0.19%)
As of 06:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$179.16 -0.60 (-0.33%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$179.56 +0.40 (+0.22%)
As of 07:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Labcorp stock logo

Labcorp NYSE:LH

$275.19 -4.11 (-1.47%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$275.48 +0.29 (+0.11%)
As of 06:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Medpace stock logo

Medpace NASDAQ:MEDP

$472.94 -0.54 (-0.11%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$475.05 +2.11 (+0.45%)
As of 07:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.